ticagrelorezetimibelow-dose rivaroxabanSGLT2 inhibitorsPCSK9 inhibitorsGLP1 agonistsmultivessel coronary artery diseaseCerebrovascular diseaseNICElong-term dual antithrombotic therapy+3 more
… long-term dual antithrombotic therapy (low-dose rivaroxaban or ticagrelor). This study compared cardiovascular outcomes of patients seen …